Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial.
about
Continuous glucose monitoring systems for type 1 diabetes mellitusIntegrated insulin pump therapy with continuous glucose monitoring for improved adherence: technology updateContinuous glucose monitoring: evidence and consensus statement for clinical useContinuous glucose monitoring: current use and future directionsCurrent application of continuous glucose monitoring in the treatment of diabetes: pros and consThe Minimum Duration of Sensor Data From Which Glycemic Variability Can Be Consistently Assessed.Real-time continuous glucose monitoring in type 1 diabetes: a systematic review and individual patient data meta-analysis.Continuous Glucose Monitoring and Global Reimbursement: An Update.Evaluation of an algorithm to guide patients with type 1 diabetes treated with continuous subcutaneous insulin infusion on how to respond to real-time continuous glucose levels: a randomized controlled trial.Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data.Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetesInsulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest riskNew-generation diabetes management: glucose sensor-augmented insulin pump therapy.Real-life utilization of real-time continuous glucose monitoring: the complete pictureEfficacy of continuous glucose monitoring in improving glycemic control and reducing hypoglycemia: a systematic review and meta-analysis of randomized trialsThe effect of real-time continuous glucose monitoring on glycemic control in patients with type 2 diabetes mellitus.Use of sensors in the treatment and follow-up of patients with diabetes mellitus.Short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes.Lessons learned from a pilot RCT of simultaneous versus delayed initiation of continuous glucose monitoring in children and adolescents with type 1 diabetes starting insulin pump therapyA randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years.HypoDE: Research Design and Methods of a Randomized Controlled Study Evaluating the Impact of Real-Time CGM Usage on the Frequency of CGM Glucose Values <55 mg/dl in Patients With Type 1 Diabetes and Problematic Hypoglycemia Treated With Multiple DaHigh reported treatment satisfaction in people with type 1 diabetes switching to latest generation insulin pump regardless of previous therapy.The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial.Use of Glucose Rate of Change Arrows to Adjust Insulin Therapy Among Individuals with Type 1 Diabetes Who Use Continuous Glucose Monitoring.Comparative analysis of the efficacy of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes mellitus.Impact of Frequent and Persistent Use of Continuous Glucose Monitoring (CGM) on Hypoglycemia Fear, Frequency of Emergency Medical Treatment, and SMBG Frequency After One YearAre Systematic Reviews and Meta-Analyses Appropriate Tools for Assessing Evolving Medical Device Technologies?The effect of real-time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial.Routine sensor-augmented pump therapy in type 1 diabetes: the INTERPRET study.The Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (RT-CGM) in Type 2 DiabetesDiabetes Technology: Uptake, Outcomes, Barriers, and the Intersection With Distress.A new-generation continuous glucose monitoring system: improved accuracy and reliability compared with a previous-generation system.Differences in Use of Glucose Rate of Change (ROC) Arrows to Adjust Insulin Therapy Among Individuals With Type 1 and Type 2 Diabetes Who Use Continuous Glucose Monitoring (CGM).Redundancy in Glucose Sensing: Enhanced Accuracy and Reliability of an Electrochemical Redundant Sensor for Continuous Glucose Monitoring.Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes.Clinical Efficacy of Two Different Methods to Initiate Sensor-Augmented Insulin Pumps: A Randomized Controlled Trial.Toward closing the loop: an update on insulin pumps and continuous glucose monitoring systems.Real-time continuous glucose monitoring system for treatment of diabetes: a systematic review.Use of continuous glucose monitoring in children and adolescents (*).Continuous glucose monitoring in children and adolescents.
P2860
Q24203866-9CC501D4-4834-43EB-91E7-1539649EF457Q26785492-1C6D60A6-6482-44D4-8CFE-88DADF308C63Q27022628-258278AE-B155-4118-A973-BB3CB9490AFAQ30354773-D91D5D2E-F751-4833-B349-4B4355394E24Q30455250-0EBC1CBD-38F0-432E-9550-77D2CFB5665FQ30827667-FF54589A-EE47-4ED8-B536-82E21CB31EC1Q31149131-129CE647-0F8E-448C-8EDE-82484C26B485Q33786148-928D4665-140B-4335-A26C-93E91188F0D6Q33873080-4E050049-652D-42D8-8E95-1F52057F4FEAQ33954163-4CD5765E-BB10-4B84-A652-5F1F5D7EBAB1Q34718324-7560DBBC-01F7-4F22-9B1B-AC081E330B16Q35179907-650C2CF9-1E6B-46B0-8A08-E1ECD774EC66Q35224968-B3430660-6FD4-4541-8364-BF153E56F93DQ35336885-8A59EBCC-36E5-48DD-A859-F2A238ECDCF2Q35337121-115D473A-CBED-4298-821F-F38A2B364DBDQ35337585-4B1C8B2C-9996-4D19-92E8-33236B8C81A3Q35594010-BB6ACDAC-4C58-4EFC-A761-56851017999FQ35620189-3A09F382-B5FC-488E-8FC3-125447D32082Q35682802-2BBE64D7-3318-42B2-A5AF-1E6F88AB904FQ35688182-DADE0797-AC6E-4BBC-9740-3530E047D3ACQ36159014-6E67A178-B575-4B8D-9A06-E07D0BAD8A46Q36159100-43880EE2-8D57-4CC0-8AB1-576C3B983BF2Q36353388-2C5374AD-9BE1-47E1-8CA4-74A5B7887D53Q36475919-72927BED-08B9-4D37-BF5F-7A1901AE5FA6Q36605704-947C0CA0-ED9B-4706-9307-B76402087211Q36638881-B49D8581-E6B7-4B01-97A7-A1A380FEF29DQ36638904-BECCA13A-7B7A-4D0C-B418-5B0D08C5606EQ36942191-082188C4-3901-4F3B-AD0C-7964709F5152Q36968348-5C5C8C42-816E-46A7-9E75-531A66B610D4Q37054667-82C2A841-CC58-4090-A0E7-8CEB6B10C930Q37054720-BAD76367-FA58-44A1-B71C-54ED12CEC385Q37192444-728D7739-B8B5-46D5-AF44-EDF7CE861FD3Q37275395-5E159C1E-3024-453C-B096-FC9D2EA22582Q37288497-660A734A-DE2C-4F1B-9CC7-C4D072A7BA65Q37400821-689A6D5B-AC7F-4B13-87C0-B9BD2A302CCCQ37492413-35EF99D5-6723-4397-BF23-9A4D0DC0114CQ37781158-FE3C1AC8-D8D9-4BE9-AC9B-7431F1F84107Q37851556-CB6C830B-EA43-4A97-B3BB-2E477E3995B9Q37979361-D94D0900-7A20-4825-8C5D-E671F2C44F58Q38025974-24F541B1-6DFC-48B0-8CCE-4595DCEC996A
P2860
Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Glycaemic impact of patient-le ...... a randomised controlled trial.
@en
Glycaemic impact of patient-le ...... a randomised controlled trial.
@nl
type
label
Glycaemic impact of patient-le ...... a randomised controlled trial.
@en
Glycaemic impact of patient-le ...... a randomised controlled trial.
@nl
prefLabel
Glycaemic impact of patient-le ...... a randomised controlled trial.
@en
Glycaemic impact of patient-le ...... a randomised controlled trial.
@nl
P2093
P1433
P1476
Glycaemic impact of patient-le ...... a randomised controlled trial.
@en
P2093
D N O'Neal
F J Cameron
G R Ambler
M A O'Connell
P G Colman
P2888
P304
P356
10.1007/S00125-009-1365-0
P50
P577
2009-04-25T00:00:00Z